Abstract
Objective
To compare changes in outpatient and acute care visits due to alcohol during the COVID-19 pandemic between individuals with and those without a history of alcohol-related health service use (AHSU).
Methods
We conducted a cross-sectional analysis of health administrative data in Ontario, Canada. The Ontario population was stratified into those with and those without 1+ health service encounter(s) due to alcohol in the past 2 years. We compared age- and sex-standardized rates of alcohol-related outpatient visits, emergency department (ED) visits, and hospitalizations during the first 15 months of the pandemic (March 2020–May 2021) to those during the same 15-month period prior to the pandemic (March 2018–May 2019).
Results
Of 13,450,750 eligible Ontarians on March 11, 2022, 129,434 (1.0%) had AHSU in the previous 2 years. Overall, rates of alcohol-related outpatient visits and hospitalizations increased, while rates of alcohol-related ED visits decreased during the pandemic. There was a similar relative increase in rates of alcohol-related outpatient visits and hospitalizations between those with and those without prior AHSU. However, the absolute increase in rates of alcohol-related outpatient visits and hospitalizations was higher among those with prior AHSU (outpatient rate difference (RD) per 10,000 population: 852.3, 95% confidence interval (CI): 792.7, 911.9; inpatient RD: 26.0, 95% CI: −2.3, 54.2) than among those without (outpatient RD: 6.5, 95% CI: 6.0, 6.9; inpatient RD: 0.4, 95% CI: 0.2, 0.7).
Conclusion
Rates of alcohol-related outpatient and inpatient care increased during the COVID-19 pandemic, and high rate of recurrent harm among individuals with pre-pandemic AHSU was an important contributor to this trend.
Résumé
Objectif
Comparer les changements dans consultations externes et les consultations en soins actifs liées à l’alcool pendant la pandémie de COVID-19 chez les personnes avec et chez celles sans antécédents d’utilisation des services de santé liée à l’alcool (USSLA).
Méthode
Nous avons effectué une analyse transversale des données administratives sur la santé de l’Ontario, au Canada. Nous avons stratifié la population ontarienne selon la présence (1+) ou l’absence de contacts avec les services de santé pour des raisons liées à l’alcool au cours des deux années antérieures. Nous avons comparé les taux de consultations externes, de consultations à l’urgence et d’hospitalisations liées à l’alcool, standardisés pour l’âge et le sexe, au cours des 15 premiers mois de la pandémie (mars 2020–mai 2021) aux taux correspondants pour la même période de 15 mois avant la pandémie (mars 2018–mai 2019).
Résultats
Sur les 13 450 750 Ontariens et Ontariennes admissibles le 11 mars 2022, 129 434 (1,0 %) avaient utilisé les services de santé pour des raisons liées à l’alcool au cours des deux années antérieures. Dans l’ensemble, les taux de consultations externes et d’hospitalisations liées à l’alcool ont augmenté, tandis que les taux de consultations à l’urgence liées à l’alcool ont diminué pendant la pandémie. Il y a eu une augmentation relative semblable des taux de consultations externes et d’hospitalisations liées à l’alcool entre les personnes avec et sans antécédents d’USSLA. Par contre, l’augmentation absolue des taux de consultations externes et d’hospitalisations liées à l’alcool a été plus élevée chez les personnes ayant des antécédents d’USSLA (différence de taux [DT] de consultations externes pour 10 000 habitants : 852,3; intervalle de confiance de 95 % [IC] : 792,7, 911,9; DT d’hospitalisations : 26,0; IC de 95 % : -2,3, 54,2) que chez les personnes sans antécédents d’USSLA (DT de consultations externes : 6,5; IC de 95 % : 6,0, 6,9; DT d’hospitalisations : 0,4; IC de 95 % : 0,2, 0,7).
Conclusion
Les taux de consultations externes et d’hospitalisations liées à l’alcool ont augmenté pendant la pandémie de COVID-19, et les taux élevés de méfaits récurrents chez les personnes ayant utilisé les services de santé pour des raisons liées à l’alcool avant la pandémie ont beaucoup contribué à cette tendance.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
At the beginning of the COVID-19 pandemic, there was concern that alcohol use and its associated health and societal harms would increase in prevalence due to pandemic-related stressors (Hobin & Smith, 2020; Stockwell et al., 2021). While the impact of the pandemic on individual-level alcohol use has been complex (Schmidt et al., 2021), this concern appears to have broadly manifested itself in North America, with surveys and alcohol sales data indicating an average increase in alcohol consumption following the onset of the pandemic (Nordeck et al., 2022; Rossow et al., 2021; Shield et al., 2022; Zipursky et al., 2021). Furthermore, the proportion of emergency department (ED) visits caused by alcohol and rates of alcohol-attributable hospitalizations and mortality have increased in Canada and the United States (Murthy & Narasimha, 2021; Myran et al., 2021b; Rennert-May et al., 2021; White et al., 2022; Zipursky et al., 2021).
Collectively, these results suggested a need for population-level interventions to reduce harmful alcohol use during the pandemic recovery period and beyond. However, it is unclear whether the risk of alcohol-related harm during the pandemic was concentrated among individuals at a high baseline risk of alcohol-related harm (e.g., those with a pre-existing alcohol use disorder [AUD]) or more broadly distributed across the population. In turn, it is unclear how much emphasis public health and clinical efforts aimed at reducing alcohol-related harms during periods of societal stressors, such as the COVID-19 pandemic, should place on targeted approaches that focus on those at the highest risk of harm versus more broad interventions aimed at reducing risk across the general population (Manuel et al., 2006; Rose et al., 2008).
Individuals with pre-existing AUD or subclinical hazardous patterns of alcohol use may have been at a disproportionately high risk of alcohol-related harm during the pandemic (Schmidt et al., 2021; Yazdi et al., 2020). The reasons for this are multifactorial and could include factors such as reduced access to inpatient addiction treatment services or an exacerbation of harmful alcohol use or AUD brought about by pandemic-related stressors (Clay & Parker, 2020; Kim et al., 2020). Indeed, isolation and psychiatric comorbidities are risk factors for relapse and increased alcohol consumption among individuals with AUD and both have increased in prevalence since the onset of the COVID-19 pandemic (Shield et al., 2022; Yazdi et al., 2020). Some surveys have suggested that individuals with pre-existing AUD have in fact reported greater increases in alcohol use during the pandemic than those without AUD and elevated rates of relapse among individuals with a history of AUD have been documented in various countries (Barrio et al., 2021; Kim et al., 2020; Schmidt et al., 2021; Schmits & Glowacz, 2021). However, no studies have examined whether individuals with pre-existing alcohol-related morbidities (including AUD) have experienced larger increases in alcohol-related health care visits during the pandemic than those without.
To address this gap in knowledge, this study used population-level health administrative data to examine changes in rates of outpatient visits, ED visits, and hospitalizations due to alcohol following the onset of the COVID-19 pandemic for all individuals in Ontario, Canada. We then compared these changes between individuals with and those without a pre-pandemic history of alcohol-related health service use (AHSU), a specific marker of AUD. Our data contain individual-level data on health service use for virtually all Ontario residents, which provides a unique opportunity to track patterns in AHSU across the entire population. This allowed for us to evaluate the relative distribution of health care visits due to alcohol between the general population and those with a documented history of harmful alcohol use both prior to and during the COVID-19 pandemic.
Material and methods
Study design
We conducted a population-based, repeated cross-sectional study of individuals living in Ontario, Canada, using linked administrative data collected from the province’s universal single-payer health care system (Ontario Health Insurance Program [OHIP]). All Ontario residents who were between the ages of 10 and 105 and were living in Ontario between January 2016 and May 2021 were eligible for inclusion. Individuals were assessed for eligibility on January 1st of each year.
Data sources
We obtained demographic data and diagnostic codes for health care visits from de-identified and linked health administrative databases. We used several databases, including the National Ambulatory Care Reporting System, which captures all ED visits in Ontario and the associated diagnostic code; the Discharge Abstract Database and Ontario Mental Health Reporting System, which capture all acute, inpatient hospitalizations in Ontario and the associated diagnostic code; the Registered Persons Database (RPDB), which includes the total number of persons at risk each month and individuals’ age and sex; and the Postal Code Conversion File, which contains information on the rurality (urban vs rural) and neighbourhood income for each person’s home address. These datasets were linked using unique encoded identifiers and analyzed at ICES. ICES is an independent, non-profit research institute whose legal status under Ontario’s health information privacy law allows it to collect and analyze health care and demographic data, without consent, for health system evaluation and improvement.
Outcomes
Our three primary outcomes were outpatient visits, ED visits, and hospitalizations due to alcohol. ED visits and hospitalizations due to alcohol were defined using methodology from the Canadian Institute for Health Information’s (CIHI) indicator on ‘hospitalizations entirely due to alcohol’ (Canadian Institute for Health Information, 2020). Briefly, a visit was considered due to alcohol when an alcohol-attributable diagnostic code from the 10th edition of the International Classification of Diseases (ICD-10) was present in the ED visit or hospitalization record (Supplementary Table 1). Outpatient visits due to alcohol were defined when the associated diagnostic code was alcohol psychosis (291) or alcoholism (303). These are the two diagnostic codes available for outpatient visits that are specific to alcohol; however, they do not capture less severe patterns of hazardous alcohol use (i.e., patterns of alcohol use that confer a risk of downstream harm but do not meet the clinical criteria for AUD). Therefore, these outpatient visits represent care for individuals with more severe patterns of alcohol use.
Exposures
The two exposures of interest for this study were (1) the COVID-19 pandemic and (2) a history of AHSU. We considered the COVID-19 pandemic to begin on March 11, 2020 (WHO declaration of pandemic). Data were available through to the end of May 2021, so we considered March 11, 2020–May 10, 2021 to be the 15-month ‘COVID-19 pandemic period’ and the equivalent 15-month period prior to the pandemic (i.e., March 11, 2018–May 10, 2019) to be the ‘pre-COVID-19 pandemic period’.
Prior AHSU was a binary variable defined by whether or not an individual had any type of health care visit (outpatient, ED, or hospitalization) attributable to alcohol in the 2 years prior to either the pre-pandemic or pandemic periods. Prior AHSU was defined using the same criteria used to identify primary outcomes. As a sensitivity analysis, prior AHSU was also broken down by three types: prior (1) alcohol-related outpatient visit, (2) alcohol-related ED visit, or (3) alcohol-related hospitalization. These groups were created hierarchically whereby an individual was placed in the ‘hospitalization’ category if they had one or more alcohol-related hospitalizations in the 2-year lookback period, in the ‘ED visit’ category if they had no alcohol-related hospitalizations but one or more alcohol-related ED visits in the 2-year lookback period, and in the ‘outpatient’ category if they had no alcohol-related hospitalizations or ED visits but one or more alcohol-related outpatient visits in the 2-year lookback period. In turn, this created a mutually exclusive severity gradient for prior AHSU, which has been previously used to categorize psychiatric comorbidities in Ontario (Klaassen et al., 2019).
Demographic variables
Differences in age structure, sex, rural-urban status, and neighbourhood income quintile were compared between those with and those without prior AHSU. Age and sex for all Ontario residents were available through the RPDB. Individuals were classified as urban or rural residents using the Statistics Canada definition, which defines a rural residence as living in a town or municipality outside of a census metropolitan area (CMA, population of 100,000 or more) or census agglomeration (CA, population of 10,000 or more). We defined neighbourhoods as dissemination areas (average 400–700 individuals) and classified neighbourhoods by income quintiles based on the average before-tax income, adjusted for household size and relative to other neighbourhoods either within the same CMA or CA or in rural Ontario.
Statistical analysis
Descriptive statistics for study variables, stratified by prior AHSU, were tabulated. To evaluate historic trends in alcohol-related health service use in Ontario, counts and per capita rates of alcohol-related outpatient visits, ED visits, and hospitalizations were gathered for each month between January 2016 and May 2021 and plotted. Counts and per capita rates of the study outcomes were also tabulated within the pre-pandemic and pandemic periods, stratified by prior AHSU. The changes in rates of each outcome between the pre-pandemic and pandemic periods across groups were evaluated using rate differences (for absolute change) and rate ratios (for relative change). All per capita rates were standardized for age and sex using the 2016 Ontario census data. Data were analyzed in SAS version 9.4 (SAS Institute Inc., 2013).
Research ethics
This project was conducted under section 45 of Ontario’s Personal Health Information Protection Act, which allows ICES to collect personal health information without consent for the purpose of health system evaluation and improvement, and approved by ICES’s Privacy and Legal Office.
Results
Descriptive statistics of the study population
At the beginning of the pandemic (March 2020), there were 13,450,750 individuals living in Ontario who were between ages 10 and 105. Of these, 129,424 (1.0%) had an AHSU event in the previous 2 years, which broke down to 31,502 (0.2%) individuals with a prior alcohol-related hospitalization, 55,349 (0.5%) individuals with a prior alcohol-related ED visit, and 42,583 (0.3%) individuals with a prior alcohol-related outpatient visit (Table 1). Of note, the hierarchical nature of these categories means that individuals in the prior ‘hospitalization’ category may have had prior alcohol-related ED or outpatient visits and individuals in the ‘ED visit’ category may have had prior alcohol-related outpatient visits.
Relative to individuals without prior AHSU, those with prior AHSU were proportionately more male (no AHSU % male = 49.0%; prior AHSU % male = 65.0%), more likely to be over the age of 19 (no AHSU % ages 10–19 = 11.0%; prior AHSU % ages 10–19 = 3.6%), more likely to live in a rural area (no AHSU % rural = 10.0%; prior AHSU % rural = 13.1%), and more likely to live in a low-income neighbourhood (no AHSU % lowest income quintile = 19.5%; prior AHSU % lowest income quintile = 28.5%). The same demographic differences between those with and those without prior AHSU were observed at the beginning of the pre-COVID-19 pandemic period (Supplementary Table 2).
Health service use due to alcohol before and during the COVID-19 pandemic
Figure 1 shows monthly data for rates (top) and absolute counts (bottom) of outpatient visits, ED visits, and hospitalizations due to alcohol between 2016 and 2021, stratified by prior AHSU (any AHSU in the past 2 years). Pre-pandemic per capita rates of all study outcomes were substantially higher among those with prior AHSU than among those without (Fig. 1). Absolute monthly counts of events due to alcohol were also higher among those with prior AHSU. Individuals with prior AHSU accounted for 73% of all outpatient visits due to alcohol, 63% of all ED visits due to alcohol, and 63% of all hospitalizations due to alcohol pre-pandemic (Table 2), despite representing 1.0% of Ontario’s population. There was also a clear gradient in severity of alcohol health service use where individuals with a history of hospitalizations due to alcohol had much higher rates of all visits due to alcohol than individuals with a history of ED visits or outpatient visits due to alcohol. For example, individuals with a history of hospitalizations due to alcohol had a higher rate of hospitalization due to alcohol during the pandemic (standardized rate: 3244) than individuals with prior ED visits due to alcohol (standardized rate: 778.7) or those with prior outpatient visits due to alcohol (standardized rate: 322.6; Table 3).
During the pandemic, there was a 21.3% increase in outpatient visits, a 14.5% decrease in ED visits, and a 6.2% increase in hospitalizations due to alcohol (Table 2). Changes in health care visits due to alcohol varied by whether or not an individual had AHSU in the prior 2 years (Table 2). After age and sex standardization, the relative increase in outpatient visits was comparable between individuals with AHSU (relative rate (RR) 1.19, 95% confidence interval (CI): 1.17–1.20) and those without (RR: 1.19, 95% CI: 1.17–1.20). Relative declines in ED visits due to alcohol were smaller for individuals with prior AHSU (RR: 0.86, 95% CI: 0.85–0.87) compared to no AHSU (RR: 0.80, 95% CI: 0.79–0.81). Relative increases in hospitalizations due to alcohol were comparable between those with prior AHSU (RR: 1.02, 95% CI: 1.00–1.05) and those with no prior AHSU (RR: 1.04, 95% CI: 1.02–1.07; Table 3). Importantly, despite similar relative changes between individuals with and those without a history of AHSU, individuals with AHSU had much larger absolute changes in all the study outcomes during the COVID-19 pandemic due to the higher baseline rate of each outcome (Table 3).
Discussion
During the first 15 months of the COVID-19 pandemic in Ontario, rates of outpatient visits and hospitalizations due to alcohol increased, whereas rates of ED visits due to alcohol decreased. Previous work from Ontario demonstrated that the decrease in rates of ED visits due to alcohol was smaller than the decrease in rates of all-cause ED visits, such that there was an increase in the proportion of total ED visits that were attributable to alcohol during the pandemic (Myran et al., 2021b). Compared to those without AHSU in the past 2 years, individuals with prior AHSU experienced a smaller relative decrease in rates of ED visits due to alcohol but similar relative increases in rates of outpatient visits and hospitalizations due to alcohol. Importantly, despite representing just 1% of the population, individuals with prior AHSU experienced much larger absolute increases in outpatient visits and hospitalizations due to alcohol during the pandemic and accounted for 76% of all outpatient visits due to alcohol, 66% of all ED visits due to alcohol, and 63% of all hospitalizations due to alcohol during the pandemic.
While trends in health service use due to alcohol are a surrogate measure of underlying trends in alcohol use in the population (insofar as not everyone who consumes alcohol will be harmed by alcohol use, and not everyone who is harmed by alcohol use will seek health care), the findings of this study are consistent with previous reports of increasing alcohol use and sales and concerns over a large increase in hazardous and harmful alcohol use during the pandemic (Myran et al., 2021c; Nordeck et al., 2022; Rossow et al., 2021; Shield et al., 2022; Zipursky et al., 2021). Indeed, both outpatient visits and hospitalizations due to alcohol increased in frequency, and, while ED visits due to alcohol decreased, this was to a much lesser degree in comparison with all-cause ED visits (Myran et al., 2021b). The primary goal of our study was to determine whether individuals with a 2-year history of AUD or hazardous alcohol use had experienced larger increases in health care visits due to alcohol during the pandemic than those without. Our results provide some reassurance that individuals with a pre-pandemic history of AUD or hazardous alcohol use did not experience a larger relative increase in health service use due to alcohol than the general population during the pandemic, as was previously hypothesized (Kim et al., 2020; Yazdi et al., 2020). However, these individuals experienced much larger absolute increases in these outcomes and accounted for the majority of health care visits entirely attributable to alcohol prior to and during the pandemic.
Prior to the pandemic, alcohol use resulted in substantial adverse health and social harms, including a major burden on the Canadian health care system (Myran et al., 2021a; Myran et al., 2019). Our study examined health care visits that were entirely attributable to alcohol and found that the majority of these visits were incurred by individuals with prior AHSU, who represented just 1% of the population. Consequently, our findings suggest that meaningful reductions in alcohol-related health service use in Ontario may be achievable through targeted interventions that expand treatment services and social supports to individuals with prior AHSU. This could include a variety of targeted services including the expansion of rapid access addiction treatment following alcohol-related ED visits and hospitalizations (Wiercigroch et al., 2020), an increased use of evidence-based pharmacotherapies for AUD (which are notoriously underutilized in Ontario (Spithoff et al., 2017)), and addressing upstream determinants (e.g., poverty, housing instability, access to health services) that contribute to recurrent AHSU in this small and often marginalized population (Bellis et al., 2016; Bloomfield, 2020; Collins et al., 2012). In addition, the large increase in alcohol-related outpatient visits may reflect expansions of outpatient virtual care services during the pandemic, which may have improved the accessibility of health services for individuals with AUD (Bhatia et al., 2021; Boschuetz et al., 2020; Drake et al., 2020; Glazier et al., 2021; Rossow et al., 2021; Schmidt et al., 2021). Importantly, increases in outpatient alcohol service use during the pandemic were greater than previously documented changes in outpatient use, which may suggest increases in harmful alcohol use and consequences in the population. An alternative possibility is that virtual care options improved access to treatment for a population that historically has struggled to access these services due to high rates of stigma and other access barriers. Further research exploring the potential role and benefits of ongoing access to virtual care for addiction medicine services is indicated.
Critically, health service encounters that are entirely attributable to alcohol use only represent an estimated 30% of all alcohol-related hospitalizations (Canadian Institute for Health Information, 2017), given that there are many health conditions to which alcohol is a partial contributor (e.g., alcohol-related cancers and cardiovascular disease). In addition, alcohol use contributes to a multitude of health and social harms (e.g., alcohol-impaired driving, interpersonal violence, and lost productivity in the workforce) that are not directly captured within health administrative data (Rehm, 2011; Rehm et al., 2017; Sherk, 2020). These partially attributable alcohol harms and other health and social harms are far more diffusely distributed across the population and require the use of public health strategies that promote population-level changes in alcohol use behaviours across the entire population (i.e., primordial or primary prevention efforts) such as minimum unit pricing, controls over alcohol marketing and promotion, and restricting retail density (Giesbrecht et al., 2011; Gruenewald, 2011; Hobin et al., 2020). Prior literature has shown that these population-level interventions are also effective at reducing alcohol use and harms across the entire drinking spectrum including high-risk drinkers (Giesbrecht et al., 2011). Consequently, the results of this study do not undermine the importance of population-level primary prevention efforts for alcohol use, but rather highlight that greater efforts to reduce the burden of alcohol harms in Canada, particularly during and post COVID-19, are indicated. These efforts should include both population-level interventions and secondary and tertiary prevention strategies for individuals with a known history of AUD.
Limitations
This study is limited by the fact that the diagnostic codes used in this study only capture an estimated half of individuals with AUD (~50% sensitivity in a previous study), despite being highly specific for AUD (~97% specificity) (Kim et al., 2012). In turn, while most individuals with a recent history of AHSU have an AUD, they do not represent all individuals with AUD. This means that many individuals who meet the clinical criteria for AUD but did not have an alcohol-related health service encounter will have been placed in the ‘no prior AHSU’ category, which may have biased the association between pre-existing alcohol-related morbidities and pandemic-induced changes in alcohol-related health service use towards the null. For this reason, we avoided using the term ‘AUD’ and instead used the descriptor ‘individuals with prior AHSU’ and it is important to recognize this distinction when interpreting the results of this study. In addition, because our definition of prior AHSU used a 2-year lookback window, many individuals with a lifetime history of AUD that had been well managed in the years leading up to the pandemic would have been placed in the ‘no prior AHSU’ category which would also bias our results towards the null. Second, the COVID-19 pandemic resulted in major changes in the delivery of health care in Ontario (e.g., virtual care) and patterns of health service use (e.g., reduction in overall ED use). As discussed previously, these changes challenge fully attributing increases in visits due to alcohol to greater alcohol consumption and harms in the population.
Conclusion
Health service use due to alcohol increased in Ontario during the first 15 months of the COVID-19 pandemic. A small portion of the Ontario population who repeatedly use health services for alcohol-related health conditions account for the majority of health service use entirely caused by alcohol in the province. This population experienced larger absolute increases but similar relative increases in health service use due to alcohol compared to the general population. Consequently, prevention efforts to reduce recurrent health care visits due to alcohol among those with pre-existing alcohol-related morbidities are indicated during public health crises to reduce health inequities and the acute burden of alcohol on the health care system.
Contributions to knowledge
What does this study add to existing knowledge?
-
Prior studies have found increases in acute care visits due to alcohol during the early phases of the COVID-19 pandemic.
-
Less data are available on longer-term changes in health service use due to alcohol and whether these changes differ for individuals with and those without pre-pandemic alcohol use disorders (AUD).
-
This study found that, overall, outpatient visits and hospitalizations due to alcohol increased over the first 15 months of the pandemic whereas ED visits due to alcohol decreased.
-
Absolute increases in health service use due to alcohol were greater for individuals with an AUD that pre-dated the start of the pandemic compared to the general population.
What are the key implications for public health interventions, practice, or policy?
-
Health service use due to alcohol increased overall during the COVID-19 pandemic, indicating that public health interventions aimed at reducing population-level alcohol consumption are warranted.
-
However, a substantial portion of health service use due to alcohol was attributed to a small proportion (1%) of the population with pre-existing AUD and these individuals experienced larger absolute increases in health service use due to alcohol than the general population during the COVID-19 pandemic.
-
Interventions specifically focusing on this high-risk subpopulation are indicated during the pandemic recovery period and future periods of health system strain to reduce health inequities and the acute burden of alcohol on the health care system.
Data availability
The dataset from this study is held securely in coded form at ICES. While legal data sharing agreements between ICES and data providers (e.g., health care organizations and government) prohibit ICES from making the dataset publicly available, access may be granted to those who meet pre-specified criteria for confidential access, available at www.ices.on.ca/DAS (email: das@ices.on.ca).
Code availability
Available on request.
References
Barrio, P., Baldaquí, N., Andreu, M., Kilian, C., Rehm, J., Gual, A., & Manthey, J. (2021). Abstinence among alcohol use disorder patients during the COVID-19 pandemic: Insights from Spain. Alcoholism: Clinical and Experimental Research, 45(1), 802–807.
Bellis, M. A., Hughes, K., Nicholls, J., Sheron, N., Gilmore, I., & Jones, L. (2016). The alcohol harm paradox: using a national survey to explore how alcohol may disproportionately impact health in deprived individuals. BMC Public Health, 16(1), 1–10.
Bhatia, R. S., Chu, C., Pang, A., Tadrous, M., Stamenova, V., & Cram, P. (2021). Virtual care use before and during the COVID-19 pandemic: A repeated cross-sectional study. Canadian Medical Association Open Access Journal, 9(1), E107–E114.
Bloomfield, K. (2020). Understanding the alcohol-harm paradox: What next? The Lancet Public Health, 5(6), e300–e301.
Boschuetz, N., Cheng, S., Mei, L., & Loy, V. M. (2020). Changes in alcohol use patterns in the United States during COVID-19 pandemic. WMJ, 119(3), 171–176.
Canadian Institute for Health Information. (2017). Alcohol harm in Canada: Examining hospitalizations entirely caused by alcohol and strategies to reduce alcohol harm. CIHI.
Canadian Institute for Health Information. (2020). Hospitalizations entirely caused by alcohol — Appendices to indicator library, May 2020. CIHI.
Clay, J. M., & Parker, M. O. (2020). Alcohol use and misuse during the COVID-19 pandemic: A potential public health crisis? The Lancet. Public Health, 5(5), e259.
Collins, S. E., Malone, D. K., Clifasefi, S. L., Ginzler, J. A., Garner, M. D., Burlingham, B., Lonczak, H. S., Dana, E. A., Kirouac, M., Tanzer, K., Hobson, W. G., Marlatt, G. A., & Larimer, M. E. (2012). Project-based Housing First for chronically homeless individuals with alcohol problems: Within-subjects analyses of 2-year alcohol trajectories. American Journal of Public Health, 102(3), 511–519.
Drake, C., Yu, J., Lurie, N., Kraemer, K., Polsky, D., & Chaiyachati, K. H. (2020). Policies to improve substance use disorder treatment with telehealth during the COVID-19 pandemic and beyond. Journal of Addiction Medicine, 14(5), e139.
Giesbrecht, N., Stockwell, T., Kendall, P., Strang, R., & Thomas, G. (2011). Alcohol in Canada: Reducing the toll through focused interventions and public health policies. CMAJ, 183(4), 450–455.
Glazier, R. H., Green, M. E., Wu, F. C., Frymire, E., Kopp, A., & Kiran, T. (2021). Shifts in office and virtual primary care during the early COVID-19 pandemic in Ontario, Canada Cmaj, 193(6), E200–E210.
Gruenewald, P. J. (2011). Regulating availability: How access to alcohol affects drinking and problems in youth and adults. Alcohol Research: Current Reviews.
Hobin, E., Schoueri-Mychasiw, N., Weerasinghe, A., Vallance, K., Hammond, D., Greenfield, T. K., … Stockwell, T. (2020). Effects of strengthening alcohol labels on attention, message processing, and perceived effectiveness: A quasi-experimental study in Yukon, Canada. International Journal of Drug Policy, 77, 102666.
Hobin, E., & Smith, B. (2020). Is another public health crisis brewing beneath the COVID-19 pandemic? Canadian Journal of Public Health, 111(3), 392–396.
Kim, H. M., Smith, E. G., Stano, C. M., Ganoczy, D., Zivin, K., Walters, H., & Valenstein, M. (2012). Validation of key behaviourally based mental health diagnoses in administrative data: Suicide attempt, alcohol abuse, illicit drug abuse and tobacco use. BMC Health Services Research, 12(1), 1–9.
Kim, J. U., Majid, A., Judge, R., Crook, P., Nathwani, R., Selvapatt, N., … Dhar, A. (2020). Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder. The Lancet Gastroenterology & Hepatology, 5(10), 886–887.
Klaassen, Z., Wallis, C. J. D., Goldberg, H., Chandrasekar, T., Sayyid, R. K., Williams, S. B., … Kulkarni, G. S. (2019). The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies. Br J Cancer, 120(8), 840–847. https://doi.org/10.1038/s41416-019-0390-0
Manuel, D. G., Lim, J., Tanuseputro, P., Anderson, G. M., Alter, D. A., Laupacis, A., & Mustard, C. A. (2006). Revisiting Rose: Strategies for reducing coronary heart disease. BMJ, 332(7542), 659–662.
Murthy, P., & Narasimha, V. L. (2021). Effects of the COVID-19 pandemic and lockdown on alcohol use disorders and complications. Current Opinion in Psychiatry, 34(4), 376.
Myran, D. T., Hsu, A. T., Smith, G., & Tanuseputro, P. (2019). Rates of emergency department visits attributable to alcohol use in Ontario from 2003 to 2016: A retrospective population-level study. CMAJ, 191(29), E804–e810. https://doi.org/10.1503/cmaj.181575
Myran, D., Hsu, A., Kunkel, E., Rhodes, E., Imsirovic, H., & Tanuseputro, P. (2021a). Socioeconomic and geographic disparities in emergency department visits due to alcohol in Ontario: A retrospective population-level study from 2003 to 2017. The Canadian Journal of Psychiatry, 67(7), 534–543. https://doi.org/10.1177/07067437211027321
Myran, D. T., Cantor, N., Pugliese, M., Hayes, T., Talarico, R., Kurdyak, P., Qureshi, D., Tanuseputro, P. (2021b). Sociodemographic changes in emergency department visits due to alcohol during COVID-19. Drug and Alcohol Dependence, 226, 108877.
Myran, D. T., Smith, B. T., Cantor, N., Li, L., Saha, S., Paradis, C., Jesseman, R., Tanuseputro, P., Hobin, E. (2021c). Changes in the dollar value of per capita alcohol, essential, and non-essential retail sales in Canada during COVID-19. BMC Public Health, 21(1), 1–9.
Nordeck, C. D., Riehm, K. E., Smail, E. J., Holingue, C., Kane, J. C., Johnson, R. M., … Kreuter, F. (2022). Changes in drinking days among United States adults during the COVID-19 pandemic. Addiction, 117(2), 331–340.
Rehm, J. (2011). The risks associated with alcohol use and alcoholism. Alcohol Research & Health, 34(2), 135.
Rehm, J., Gmel, G. E., Sr., Gmel, G., Hasan, O. S. M., Imtiaz, S., Popova, S., Probst, C., Roerecke, M., Room, R., Samokhvalov, A. V., Shield, K. D., Shuper, P. A. (2017). The relationship between different dimensions of alcohol use and the burden of disease—an update. Addiction, 112(6), 968-1001. https://doi.org/10.1111/add.13757
Rennert-May, E., Leal, J., Thanh, N. X., Lang, E., Dowling, S., Manns, B., … Ronksley, P. E. (2021). The impact of COVID-19 on hospital admissions and emergency department visits: A population-based study. PLoS One, 16(6), e0252441.
Rose, G. A., Khaw, K.-T., & Marmot, M. (2008). Rose’s strategy of preventive medicine: the complete original text. Oxford University Press.
Rossow, I., Bye, E. K., Moan, I. S., Kilian, C., & Bramness, J. G. (2021). Changes in alcohol consumption during the COVID-19 pandemic—Small change in total consumption, but increase in proportion of heavy drinkers. International Journal of Environmental Research and Public Health, 18(8), 4231.
SAS Institute Inc. (2013). SAS/ACCESS® 9.4 Interface to ADABAS: Reference. SAS Institute Inc., Cary, NC, USA.
Schmidt, R. A., Genois, R., Jin, J., Vigo, D., Rehm, J., & Rush, B. (2021). The early impact of COVID-19 on the incidence, prevalence, and severity of alcohol use and other drugs: A systematic review. Drug and Alcohol Dependence, 228, 109065.
Schmits, E., & Glowacz, F. (2022). Changes in alcohol use during the COVID-19 pandemic: Impact of the lockdown conditions and mental health factors. International Journal of Mental Health and Addiction, 20(2), 1147–1158. https://doi.org/10.1007/s11469-020-00432-8
Sherk, A. (2020). At-a-glance-The alcohol deficit: Canadian government revenue and societal costs from alcohol. Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice, 40(5-6), 139.
Shield, K. D., Chrystoja, B. R., Ali, S., Sohi, I., Rehm, J., Nigatu, Y. T., … Wells, S. (2022). Changes in alcohol consumption in Canada during the COVID-19 pandemic: Associations with anxiety and self-perception of depression and loneliness. Alcohol and Alcoholism, 57(2), 190–197.
Spithoff, S., Turner, S., Gomes, T., Martins, D., & Singh, S. (2017). First-line medications for alcohol use disorders among public drug plan beneficiaries in Ontario. Can Fam Physician, 63(5), e277–e283.
Stockwell, T., Andreasson, S., Cherpitel, C., Chikritzhs, T., Dangardt, F., Holder, H., … Sherk, A. (2021). The burden of alcohol on health care during COVID-19. Drug and Alcohol Review, 40(1), 3–7.
White, A. M., Castle, I.-J. P., Powell, P. A., Hingson, R. W., & Koob, G. F. (2022). Alcohol-related deaths during the COVID-19 pandemic. JAMA, 327(17), 1704–1706.
Wiercigroch, D., Sheikh, H., & Hulme, J. (2020). A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use. Substance Abuse Treatment, Prevention, and Policy, 15(1), 1–10.
Yazdi, K., Fuchs-Leitner, I., Rosenleitner, J., & Gerstgrasser, N. W. (2020). Impact of the COVID-19 pandemic on patients with alcohol use disorder and associated risk factors for relapse. Frontiers in Psychiatry, 11, 1470.
Zipursky, J. S., Stall, N. M., Silverstein, W. K., Huang, Q., Chau, J., Hillmer, M. P., & Redelmeier, D. A. (2021). Alcohol sales and alcohol-related emergencies during the COVID-19 pandemic. Annals of Internal Medicine, 174(7), 1029–1032.
Acknowledgements
This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health (MOH) and the Ministry of Long-Term Care (MLTC).
Funding
DM was supported with a Research Fellow Salary Award from the Canadian Institutes of Health Research and the University of Ottawa Department of Family Medicine. EF was supported with a Canada Graduate Scholarship-Doctoral from the Canadian Institutes of Health Research. PT was supported by a PSI Graham Farquharson Knowledge Translation Fellowship. Parts of this material are based on data and information compiled and provided by Ontario MOH and Canadian Institute for Health Information. The analyses, conclusions, opinions and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred.
Author information
Authors and Affiliations
Contributions
DM, EF, CM, PK, MS, and PT conceptualized the study. MP and CM collected the data. DM, EF, MP, and MS analyzed the data. DM, EF, CM, and MS wrote the first draft of the manuscript. All authors edited the manuscript and approved the final version.
Corresponding author
Ethics declarations
Ethics approval
The use of the data in this project is authorized under section 45 of Ontario’s Personal Health Information Protection Act (PHIPA) and does not require review by a Research Ethics Board.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(DOCX 23 kb)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Myran, D., Friesen, E.L., Pugliese, M. et al. Changes in health service use due to alcohol during the COVID-19 pandemic among individuals with and individuals without pre-existing alcohol-related medical diagnoses. Can J Public Health 114, 185–194 (2023). https://doi.org/10.17269/s41997-023-00739-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.17269/s41997-023-00739-8